Floatz logo

Clobazam

Epilepsia Partialis Continua

The Cooper Health SystemSmall moleculePhase 3Dormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Epilepsia Partialis Continua cohort.

Asset / SponsorPhaseRating
Carisbamate
SK Life Science, Inc.
Phase 3BB
Lorazepam
The Cooper Health System
Phase 3B
Clonazepam
The Cooper Health System
Phase 3B

Same molecule, other indications

Clobazam is also rated in:

generalized epilepsyDormant
BB
Indicative ·
65 / 100
View asset →
epilepsyDormant
BB
Indicative ·
65 / 100
View asset →
anxiety disorderDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →